The 2026 Tour de France Femmes marks a historic turning point after more than a century of institutional exclusion and neglect of women’s competitive cycling. While the men’s race began in 1903, the women's counterpart under the same Amaury Sport Organization did not truly take form until 2022. This delay was driven by long-standing myths about female fragility, lack of interest, and commercial value, which were never supported by evidence but nonetheless shaped decades of underinvestment and media invisibility. The recent success of the Tour de France Femmes demonstrates that with proper financial backing, marketing, and infrastructure, women’s cycling can engage audiences and thrive.

For over 100 years, traditions and policies in cycling and broader sports contexts effectively barred women from serious competitive opportunities. In France, as elsewhere, early 20th-century medical and sporting authorities propagated unscientific beliefs about women's physical limitations, sidelining female athletes. It took trailblazers like Alice Milliat, who championed international women’s sports contests in the 1920s, to challenge these biased institutions and press for inclusion. Nevertheless, events such as the Tour de France Féminin in the 1980s and its successors failed not for lack of talent or interest, but due to inadequate funding, minimal media presence, and brand suppression by organizers.

These systemic barriers created a vicious cycle where limited exposure deterred sponsors, which kept budgets low and hampered race sustainability. The Union Cycliste Internationale (UCI) enforced restrictive race distance limits for women based on outdated and disproven health concerns, further marginalizing female cyclists. Contrary to persistent claims, the global cycling community has shown significant female participation—women make up roughly 40% of cyclists worldwide, and nearly half of U.S. bike riders are women. Yet, competitive pathways remain underdeveloped, perpetuating the false narrative that lack of interest explains low representation in elite competition.

Scientific research also debunks the myth that women’s bodies cannot endure the demands of a grand tour race. Studies highlight women’s physiological advantages in endurance and fatigue resistance, with performance gaps shrinking in longer-distance events. Despite this, sports science historically prioritized male physiology, leaving women's capacities understudied and undervalued. Today’s Tour de France Femmes, with nine challenging consecutive stages and a growing fanbase, contradicts outdated assumptions and underscores that equitable investment and promotion are key to expanding women’s competitive cycling and elevating the sport’s future.